VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $783,000 | +146.2% | 32,000 | +102.5% | 0.18% | +121.2% |
| Q2 2016 | $318,000 | +37.1% | 15,800 | +78.9% | 0.08% | +37.9% |
| Q1 2016 | $232,000 | -62.0% | 8,830 | +47.2% | 0.06% | -62.6% |
| Q4 2015 | $610,000 | -31.4% | 6,000 | +50.0% | 0.16% | -20.5% |
| Q2 2015 | $889,000 | +12.0% | 4,000 | 0.0% | 0.20% | +12.7% |
| Q1 2015 | $794,000 | +38.8% | 4,000 | 0.0% | 0.17% | +38.4% |
| Q4 2014 | $572,000 | -68.9% | 4,000 | -71.4% | 0.12% | -69.7% |
| Q3 2014 | $1,837,000 | – | 14,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |